CARLIE CROOKS: Open Payments
NPI 1992350557 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Genentech USA, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $28 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: Columvi, Vyloy, BRUKINSA, Tivdak, PLUVICTO, ULTOMIRIS, LYNPARZA, IMFINZI.
Industry payments across OH — which companies pay providers there.
